bioRxivImmunologyPreprint
Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery and enhanced humoral immune responses
Namit ChaudharyiD, Holly ColemaniD, Elias V. Paolone, Jiancheng Yu, Amir LedbetteriD, Ashley A. LemniosiD, Agnes A. Walsh, Heikyung SuhiD, Alexander Wang, Maryam M. Mansoor, JoLynn B. GiancolaiD, Mariane B. MeloiD, Amber M. Rauch, Erika S. LangsfeldiD, Urvi R. ParlikariD, Marisa O. PachecoiD, Carly A. Williams, Hans H. FunkeiD, Robert L. GarceaiD, Theodore W. RandolphiD, Darrell J. IrvineiD
Abstract
Technologies that simplify complex dosing regimens as single-shot immunizations may be important for vaccines against difficult to neutralize pathogens. Here we characterized delivery mechanisms of core-shell microparticles comprising clinically-relevant HIV immunogen formulations spray-dried to form solid spherical microparticles and subsequently coated with a nanoscopic alumina shell using atomic layer deposition (ALD). ALD particles exhibited a time delay in antigen release programmed by the alumina shell followed by prolonged antigen release, which steadily accumulated in antigen-presenting cells at the injection site and draining lymph nodes and accumulated on follicular dendritic cells in B cell follicles. ALD vaccines elicited continuous expansion of antigen-specific germinal center B cells over 8 weeks, serum antibody responses with >10-fold slower antigen-binding off-rates, and 2-fold more long-lived plasma cells compared to traditional bolus vaccination with potent adjuvants. Single administration ALD technology thus promotes key events in the primary immune response important for vaccines against HIV and other challenging pathogens.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Atomic Layering Thermostable Antigen and Adjuvant (ALTA(R)) platform provides unique antigen delivery system through controlled release to improve immune response to vaccination
Keith A. Strand, Heather D’Angelo, … Sky W. Brubaker·bioRxiv·Jan 5, 2026
- Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansion
Kristen A. Rodrigues, Yiming J. Zhang, … Darrell J. Irvine·Science Translational MedicinePeer-reviewed·Jun 18, 2025
- Subunit Vaccination Using Atomic Layering Thermostable Antigen and Adjuvant (ALTA(R)) Platform Elicits Enhanced Humoral and Cellular Immune Responses
Daria L. Ivanova, Matthew Lewis, … Sky W. Brubaker·Frontiers in ImmunologyPeer-reviewed·Apr 15, 2026
- A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.
D. P. Mayer, M. Nelson, … J. S. Weinstein·bioRxiv·Jan 30, 2024
- Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine
H. Miwa, O. Q. Antao, … D. Di Carlo·bioRxiv·Dec 16, 2022
- Targeting HIV Env immunogens to B cell follicles in non-human primates through immune complex or protein nanoparticle formulations
J. T. Martin, C. T. Cottrell, … D. J. Irvine·bioRxiv·Feb 19, 2020